The companies have signed an agreement to integrate Amyris lab services with Genome Compiler's synthetic biology software
The FoldIt creators have a new citizen science game for synthetic biology, says Carolyn Graybeal at the Citizen Science Salon.
£30M will go toward the creation of three new Synthetic Biology Research Centres, while £8M will be used for research developing synthetic DNA fragments.
In Science this week: new factor in DNA double-strand break repair process, and more.
Genome Compiler will integrate DNA2.0's gene synthesis services into its computer-aided synthetic biology design platform.
NEW YORK (GenomeWeb) – Researchers from New York University Langone School of Medicine have developed a synthetic biology method to linearize circular DNA molecules in vivo.
NEW YORK (GenomeWeb) – Genome Compiler and De Novo DNA today announced a collaboration to create a comprehensive synthetic biology solution.
NEW YORK (GenomeWeb) – Tauriga Sciences said on Thursday that it completed a $600,000 private placement with unnamed institutional and accredited individual investors.
GenomeWeb Daily News was provided incorrect information that the $5 million was in addition to the $29.4 million that Synlogic raised in July. The summer financing included the $5 million.
NEW YORK (GenomeWeb) – Using a synthetic biology-based approach, researchers from the J. Craig Venter Institute and Kansas State University found that a bat influenza virus uncovered in 2009 poses little-to-no pandemic threat to humans.
In PLOS this week: transcriptomic and genomic analysis of prostate cancer by ancestry, genes linked to liver function in Korean cohort, and more.
British Columbia is incorporating genomics into its tracking of the ongoing COVID-19 outbreak, Business in Vancouver reports.
An analysis by the Personalized Medicine Coalition finds that about a quarter of new drugs approved in 2019 by the US Food and Drug Administration were personalized medicines.
The governor of New York has proposed a five-year plan to study the genomes of people with or who are at high risk of developing Alzheimer's disease.